SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950135-08-001004
Filing Date
2008-02-14
Accepted
2008-02-14 14:46:18
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL BIOTECH FUND II, L.P.RA CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 RENOVIS, INC. (RA CAPITAL MANAGEMENT, LLC) SC 13G/A b68591risc13gza.htm SC 13G/A 94381
  Complete submission text file 0000950135-08-001004.txt   96405
Mailing Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080 650-266-1400
RENOVIS INC (Subject) CIK: 0001118361 (see all company filings)

IRS No.: 943353740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80111 | Film No.: 08613753
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A